Moderna: Blowout Quarterly Earnings Won't Last Forever - But Q1 2022 Was Certainly OneSeeking Alpha • 05/05/22
This Prediction From Moderna's CEO Should Eliminate Investors' Biggest WorryThe Motley Fool • 05/05/22
Moderna expects vaccine sales to increase in the back half of 2022 with fall-winter booster in developmentProactive Investors • 05/04/22
Moderna, Inc. (MRNA) CEO Stephane Bancel on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22
Moderna's stock soars 8% after beating revenue, earnings expectations for the quarterMarket Watch • 05/04/22
Moderna sold $5.9 billion in Covid shots in the first quarter as it delivers better-than-expected earningsCNBC • 05/04/22
Moderna Reports First Quarter 2022 Financial Results and Provides Business UpdatesAccesswire • 05/04/22